Team message

                                                                                                                                             “Somewhere, something incredible is waiting to be known”. Carl Sagan

Target Medicals is a privately held biotech company focused on discovery and development of novel and highly selective compounds for treatment of serious drug-resistant infectious diseases (MDR/XDR forms of tuberculosis and fungal infections) and endocrine disorders (aldosterone-mediated arterial hypertension and diabetes). Based on our achievements in research of clinically relevant Cytochromes P450 – а special enzymes, playing a crucial role in bioregulation processes in human and microorganisms – we have developed a unique technological platform for P450-targeted drug discovery.

Our mission

Diseases have no borders. We work to turn science into a life-saving therapeutics for unmet medical needs to help patients worldwide.

Our team

Gilep Andrei
Director R&D, PhD

Postdoctoral training at UT Southwestern Medical Center, Dallas, Tx (1998-2001);

>20 years in P450s research and >15 years in R&D project management;

>15 product developments (enzymes and IVDs);

>40 publications in peer reviewed journals, including PNAS, JACS, BBA, Proteomics

Strushkevich Natallia
Chief scientist, PhD

Postdoctoral training at University of Osaka (Japan) and University of Toronto (Canada);

7 years of experience as a project leader on human cytochrome P450 (CYP) at Structural Genomics Consortium (Canada);

>20 publications in peer reviewed journals, including PNAS, JACS, JMB;

15 crystal structures deposited to PDB

Kliuchenovich Alexei
General Director, MD

3 years experience as physician (intensive care and anesthesiology);

9 years of entrepreneurship and management in medical devices and biotech products;

Professional degree in medicine; second degree – economics/business administration.